BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24816340)

  • 1. Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus.
    Pisoni CN; Muñoz SA; Carrizo C; Cosatti M; Álvarez A; Dubinsky D; Bresan E; Russo R; Borgia E; García M; Sansinanea P; Basta MC; D'Amico MA; Barreira JC; Lancioni E; Soriano E; Cunto Cd; Beron A; Eimon A
    Reumatol Clin; 2015; 11(2):73-7. PubMed ID: 24816340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients.
    Gerli R; Caponi L; Tincani A; Scorza R; Sabbadini MG; Danieli MG; De Angelis V; Cesarotti M; Piccirilli M; Quartesan R; Moretti P; Cantoni C; Franceschini F; Cavazzana I; Origgi L; Vanoli M; Bozzolo E; Ferrario L; Padovani A; Gambini O; Vanzulli L; Croce D; Bombardieri S
    Rheumatology (Oxford); 2002 Dec; 41(12):1357-66. PubMed ID: 12468814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus.
    Quintana G; Coral-Alvarado P; Aroca G; Patarroyo PM; Chalem P; Iglesias-Gamarra A; Ruiz AI; Cervera R
    Autoimmun Rev; 2010 Sep; 9(11):750-5. PubMed ID: 20601199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.
    Carreño L; López-Longo FJ; Monteagudo I; Rodríguez-Mahou M; Bascones M; González CM; Saint-Cyr C; Lapointe N
    Lupus; 1999; 8(4):287-92. PubMed ID: 10413207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted specificity of anti-ribosomal P antibodies to SLE patients in Israel.
    Shovman O; Zandman-Goddard G; Gilburd B; Blank M; Ehrenfeld M; Bardechevski S; Stojanovich L; Langevitz P; Shoenfeld Y
    Clin Exp Rheumatol; 2006; 24(6):694-7. PubMed ID: 17207387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody.
    Watanabe T; Sato T; Uchiumi T; Arakawa M
    Lupus; 1996 Jun; 5(3):178-83. PubMed ID: 8803887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.
    Li J; Shen Y; He J; Jia R; Wang X; Chen X; Wang D; Han L; Zhu L; Chi X; Saschenbrecker S; Dähnrich C; Stöcker W; Schlumberger W; Li ZG
    J Clin Lab Anal; 2013 Mar; 27(2):87-95. PubMed ID: 23400861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
    Aldar H; Lapa AT; Bellini B; Sinicato NA; Postal M; Fernandes PT; Costallat LT; Marini R; Appenzeller S
    Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.
    Barkhudarova F; Dähnrich C; Rosemann A; Schneider U; Stöcker W; Burmester GR; Egerer K; Schlumberger W; Hiepe F; Biesen R
    Arthritis Res Ther; 2011 Feb; 13(1):R20. PubMed ID: 21310064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestation of systemic lupus erythematosus in patients with antiribosomal P protein antibodies.
    Olesińska M; Chwalińska-Sadowska H; Wiesik-Szewczyk E; Mielnik P; Zabek J
    Pol Arch Med Wewn; 2010 Mar; 120(3):76-81. PubMed ID: 20332713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients.
    Valões CC; Molinari BC; Pitta AC; Gormezano NW; Farhat SC; Kozu K; Sallum AM; Appenzeller S; Sakamoto AP; Terreri MT; Pereira RM; Magalhães CS; Ferreira JC; Barbosa CM; Gomes FH; Bonfá E; Silva CA;
    Lupus; 2017 Apr; 26(5):484-489. PubMed ID: 28394238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile.
    Carmona-Fernandes D; Santos MJ; Canhão H; Fonseca JE
    BMC Med; 2013 Apr; 11():98. PubMed ID: 23557114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
    Agmon-Levin N; Gilburd B; Kivity S; Katz BS; Flitman-Katzevman I; Shoenfeld N; Paran D; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Jul; 11(7):403-6. PubMed ID: 19911490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease.
    Massardo L; Burgos P; Martínez ME; Pérez R; Calvo M; Barros J; González A; Jacobelli S
    Lupus; 2002; 11(6):379-83. PubMed ID: 12139376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus.
    Mei YJ; Wang P; Jiang C; Wang T; Chen LJ; Li ZJ; Pan HF
    Clin Rheumatol; 2018 Mar; 37(3):703-707. PubMed ID: 29151171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.